- RESEARCH HIGHLIGHT
People with a deadly form of pancreatic cancer survive longer on a drug that blocks the activity of a family of mutant proteins.
People with a deadly form of pancreatic cancer survive longer on a drug that blocks the activity of a family of mutant proteins.